SCM
Silverarc Capital Management’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-921,137
| Closed | -$7.18M | – | 68 |
|
|
2024
Q4 | $7.18M | Sell |
921,137
-300,225
| -25% | -$2.34M | 1.57% | 21 |
|
|
2024
Q3 | $13.2M | Buy |
1,221,362
+15,148
| +1% | +$164K | 2.96% | 9 |
|
|
2024
Q2 | $10.2M | Buy |
1,206,214
+169,547
| +16% | +$1.43M | 2.4% | 11 |
|
|
2024
Q1 | $6.97M | Buy |
1,036,667
+69,919
| +7% | +$470K | 1.93% | 19 |
|
|
2023
Q4 | $5.68M | Buy |
966,748
+315,376
| +48% | +$1.85M | 1.69% | 21 |
|
|
2023
Q3 | $6.35M | Buy |
651,372
+31,372
| +5% | +$306K | 1.93% | 16 |
|
|
2023
Q2 | $7.34M | Buy |
620,000
+40,736
| +7% | +$482K | 2.27% | 12 |
|
|
2023
Q1 | $6.25M | Buy |
579,264
+400,264
| +224% | +$4.32M | 2.58% | 13 |
|
|
2022
Q4 | $2.07M | Sell |
179,000
-427,608
| -70% | -$4.94M | 0.59% | 46 |
|
|
2022
Q3 | $9.05M | Sell |
606,608
-214,346
| -26% | -$3.2M | 3.06% | 5 |
|
|
2022
Q2 | $7.41M | Buy |
820,954
+247,255
| +43% | +$2.23M | 2.28% | 9 |
|
|
2022
Q1 | $4.3K | Sell |
573,699
-277,236
| -33% | -$2.08K | 1.78% | 14 |
|
|
2021
Q4 | $7.3M | Buy |
850,935
+173,035
| +26% | +$1.48M | 2.96% | 8 |
|
|
2021
Q3 | $5.7M | Buy |
677,900
+479,655
| +242% | +$4.03M | 3.22% | 7 |
|
|
2021
Q2 | $1.61K | Buy |
198,245
+78,245
| +65% | +$635 | 0.72% | 49 |
|
|
2021
Q1 | $1.05M | Sell |
120,000
-115,066
| -49% | -$1.01M | 0.57% | 51 |
|
|
2020
Q4 | $2.64M | Buy |
+235,066
| New | +$2.64M | 1.53% | 23 |
|